EX-99.1 2 d129193dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Notification of managers`transactions according to article 19 MAR

Via Fax to BaFin (+49(0)228/4108-62963) and to the issuer

 

1    Details of the person discharging managerial responsibilities/person closely associated
a)    Name    Michael Brosnan
2    Reason for the notification
a)    Position/status    Member of the Supervisory Board of MorphoSys AG
b)    Initial notification/Amendment    Initial notification
3    Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)    Name    MorphoSys AG
b)    LEI    529900493806K77LRE72
4    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)   

Description of the financial instrument. type of instrument

Identification code

   

American Depositary Shares (ADS), CUSIP: 617760202; ratio: 4 ADS = 1 ordinary share of MorphoSys AG (ISIN: DE0006632003)

For trade on Nasdaq

b)    Nature of the transaction    Acquisition
c)    Price(s) and volume(s)   

 

     Price(s)      Volume(s)  
   22.73US-$        227,300.00US-$    

 

d)   

Aggregated information

 

- Aggregated volume

 

- Price

   

 

227,300.00 US-$

 

22.73 US-$

e)    Date of the transaction    2021-03-16; UTC+1
f)    Place of the transaction    Nasdaq

 

(1)

Commission Delegated Regulation (EU) 2016/522 of 17 December 2015 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council as regards an exemption for certain third countries public bodies and central banks. the indicators of market manipulation. the disclosure thresholds. the competent authority for notifications of delays. the permission for trading during closed periods and types of notifiable managers’ transactions (see page 1 of this Official Journal).